Fukai WangXiaowei MaJing YeChenzhi ShiYun ChenZhicai YuTianming LiDonglei YangMin LiPengfei Wang
Detection of viral infections (e.g., SARS-CoV-2) with high precision is critical to disease control and treatment. There is an urgent need to develop point-of-care detection methods to complement the gold standard laboratory-based PCR assay with comparable sensitivity and specificity. Herein, we developed a method termed mCAD to achieve ultraspecific point-of-care detection of SARS-CoV-2 RNA while maintaining high sensitivity by programming multiplex rolling circle amplification and toehold-mediated strand displacement reactions. RCA offers sufficient amplification of RNA targets for subsequent detection. Most importantly, a multilayer of detection specificity is implemented into mCAD via sequence-specific hybridization of nucleic acids across serial steps of this protocol to fully eliminate potential false-positive detections. Using mCAD, we demonstrated a highly specific, sensitive, and convenient visual detection of SARS-CoV-2 RNA from both synthetic and clinical samples, exhibiting performance comparable to qPCR. We envision that mCAD will find its broad applications in clinical prospects for nucleic acid detections readily beyond SARS-CoV-2 RNA.
Fukai Wang (9301636)Xiaowei Ma (113432)Jing Ye (94291)Chenzhi Shi (17403076)Yun Chen (279569)Zhicai Yu (12007931)Tianming Li (412080)Donglei Yang (5958056)Min Li (12799)Pengfei Wang (123133)
Hyobeen LeeDong‐Min KimDong‐Eun KimDong-Eun KimDong-Eun Kim
Yunlei ZhouBingchen LiMinghui WangJun WangHuanshun YinShiyun Ai
Lingwen ZengOmar MukamaXuewen LuShilin CaoDonghai Lin
Lirong ZhangGuichi ZhuChun‐yang Zhang